EyePoint, Inc. Payments to Acquire Debt Securities, Available-for-sale
EyePoint, Inc. (EYPT) reported Payments to Acquire Debt Securities, Available-for-sale of $139.10 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2023-03-10
- EyePoint, Inc. payments to acquire debt securities, available-for-sale for fiscal 2022 was $139.10M, a 321.52% increase from fiscal 2021.
- EyePoint, Inc. payments to acquire debt securities, available-for-sale for fiscal 2021 was $33.00M.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|
| 2022-12-31 | $139.10M 10-K · filed 2023-03-10 |
| 2021-12-31 | $33.00M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |